# BCB Bancorp Inc: overview BCBP · Nasdaq · CIK 1228454 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/bcbp.md) · [Financials](/companies/bcbp/financials.md) · [Filings](/companies/bcbp/filings.md) · [Insiders](/companies/bcbp/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.36](/filings/0001228454-25-000015.md) | not reported | [(0.51)](/filings/0001228454-26-000006.md) | [0.18](/filings/0001228454-26-000008.md) | [0.22](/filings/0001228454-25-000015.md) | not reported | [0.26](/filings/0001228454-26-000006.md) | [(0.85)](/filings/0001228454-26-000008.md) | | Free cash flow | $m | [43.4 d](/filings/0001228454-25-000015.md) | [6.8 d](/filings/0001228454-26-000004.md) | [4.7](/filings/0001228454-26-000006.md) | [10.2 d](/filings/0001228454-26-000008.md) | [8.5 d](/filings/0001228454-25-000015.md) | [11.5 d](/filings/0001228454-26-000004.md) | [4.9](/filings/0001228454-26-000006.md) | [9.3 d](/filings/0001228454-26-000008.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [1.92](/filings/0001228454-24-000003.md) | [2.58](/filings/0001228454-25-000003.md) | [1.70](/filings/0001228454-26-000004.md) | [0.99](/filings/0001228454-26-000004.md) | [(0.84)](/filings/0001228454-26-000004.md) | | Free cash flow | $m | [45.6](/filings/0001228454-24-000003.md) | [40.4](/filings/0001228454-25-000003.md) | [30.6](/filings/0001228454-26-000004.md) | [66.5](/filings/0001228454-26-000004.md) | [34.9](/filings/0001228454-26-000004.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bcbp/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $13.7m | 1,282,406 | | Added +52,123 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $8.0m | 750,081 | | Reduced −137,038 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $7.6m | 713,181 | | Added +42,984 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $5.2m | 480,594 | | Added +135,400 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $4.7m | 436,561 | | Reduced −3,991 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $3.4m | 318,552 | | Added +41,508 | | [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $2.7m | 304,725 | | Reduced −70,778 | | [MALTESE CAPITAL MANAGEMENT LLC](/funds/1040762.md) | 2026-06-30 | $2.4m | 224,702 | | New +224,702 | | [Quantinno Capital Management LP](/funds/1759654.md) | 2026-06-30 | $2.1m | 192,140 | | Added +50,236 | | [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $1.9m | 173,937 | | Added +38,481 | ## Recent filings [All 1,101 filings](/companies/bcbp/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-29 | 07:49 ET | [8-K](/filings/0001193125-26-437028.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-437028 | | 2026-10-09 | 07:45 ET | [DEF 14A](/filings/0001174947-26-000915.md) | Proxy statement, period 2026-11-18 | 0001174947-26-000915 | | 2026-10-07 | 16:52 ET | [8-K](/filings/0001193125-26-417038.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-417038 | | 2026-09-25 | 15:25 ET | [8-K](/filings/0001193125-26-402710.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-402710 | | 2026-09-18 | 17:28 ET | [8-K](/filings/0001193125-26-395743.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-395743 | | 2026-09-17 | 21:01 ET | [8-K](/filings/0001193125-26-393461.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-393461 | | 2026-09-16 | 16:53 ET | [8-K](/filings/0001193125-26-393183.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-393183 | | 2026-09-03 | 16:03 ET | [8-K](/filings/0001193125-26-381867.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-26-381867 | | 2026-08-10 | 13:58 ET | [10-Q](/filings/0001228454-26-000008.md) | Quarterly report, period 2026-06-30 | 0001228454-26-000008 | | 2026-08-07 | 11:43 ET | [8-K](/filings/0001193125-26-339642.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-339642 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001228454-26-000004.md), filed Mar 9, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1228454 - Tickers: BCBP - Exchange: Nasdaq - SIC code: 6035 Savings Institution, Federally Chartered - State of incorporation: NJ - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 20:18 ET. No prices; not investment advice.